All Type of News
Trius Therapeutics initiates phase 3 clinical trial of oral torezolid phosphate for treatment of ABS
Trius Therapeutics, Inc. has conducted its Phase 3 clinical study of the oral dosage form of torezolid phosphate (DA-7218) for the treatment of acute bacterial skin and skin structure infections (ABSSSI), Dong-A Pharm...
KMA, KPA should have self-disciplinary action right
A lawyer said on August 31 that the government should provide a self-disciplinary action right to officially approved organizations, such as Korea Medical Association and Korea Pharmaceutical Association, to let them ...
Pharmacies opening at night hit by sluggish sales
People are more easily able to buy medicine at night or on holidays at designated pharmacies, but pharmacists are complaining of smaller sales.
A pharmacist in Bucheon, Kyunggi Province, said on August 30 that he r...
KOTRA picks Medison as one of World Champ enterprise
Korea Trade Investment Promotion Agency (KOTRA) said on August 31 that it has designated five small-sized firms, which have the potential to become giants and dominate in global markets in the not-so-distant future.
...
BIO KOREA 2010, Korea’s largest exhibition & conference on Biotech in Seoul, September 1-3
The 5th BIO KOREA 2010 Conference & Exhibition will be held from September 1 to 3, 2010 at COEX in Seoul, Korea. COEX, the venue is the largest exhibition center. Located at the business district of downtown Seoul, CO...
Battle gets fierce over generic Ultracet market
Korean drug manufacturers have waged fiercer campaigns to raise their generic Ultracet (tramadol + acetaminophen) market share amid forecasts that their revenues will fall gradually due to stronger competition from a ...
Government to restrict joint bioequivalence until 2013
The government plans to extend the restriction of joint/commissioned bioequivalence testing for the next three years, although the related provision is to expire in November this year.
The Korea Food and Drug Admin...
Prices of 6 original drugs to fall by 20%
The Ministry of Health and Welfare Affairs said on August 27 that the prices of six original medicines, including GlaxoSmithKline’s Hepsera, MSD’s Cosopt, Abbott’s Hokunalin and Roche’s Tamilfu, will be decreased by 2...
Korea to vaccinate 18 million people
In a move to contain seasonal influenza fears, the government is expected to secure 18 million doses of vaccine for the influenza virus this year.
As part of plan, the Public Procurement Service said on August 26 t...
Complaint against KBS over misreport on rebate
The Korean Pharmaceutical Association said on August 27 it has asked Korea Broadcasting System (KBS) for what it claimed to be a misreport on pharmacy rebate.
The media said on its recent news program that about 20...
